Pipeline and approval signals
Search agency notices, approvals, recalls, and regulatory updates from global authorities.
1,099 of 1,099 tracked regulatory updates from 40 agencies and publishers, page 10 of 22.
76th WHO Regional Committee for Africa: Strategy for financing the future of health in the WHO African Region, 2026–2035IFPMA Global76th WHO Regional Committee for Africa – A new era of health for Africa: United action for Vision 2035IFPMA Global100 Day milestone of Ebola Bundibugyo outbreak must be a “wake up call” for pandemic preparedness, says pharma industryIFPMA GlobalSAHPRA calls on patients to report medicine side effectsSAHPRA South AfricaBeyond the Lab: SAHPRA introduces NWU students to careers in Radiation Science and Regulatory ScienceSAHPRA South AfricaImportant Notice on Cybersecurity ThreatsSAHPRA South AfricaSAHPRA Reinforces Its Commitment to Radiation Safety at IAEA General ConferenceSAHPRA South AfricaSAHPRA and Lesotho strengthen regional collaboration for regulatory excellenceSAHPRA South AfricaSouth Africa Maintains WHO Maturity Level 3 (ML3) for Vaccine RegulationSAHPRA South AfricaSAHPRA Reaffirms the Safety of Routine Childhood VaccinationSAHPRA South AfricaAngiotensin-Converting Enzyme Inhibitor-Induced Angioedema: Risk of Serious and Fatal OutcomesSAHPRA South AfricaSAHPRA inspires TUT students to pursue careers in health regulationSAHPRA South AfricaSAHPRA recalls certain batches of Enalapril 10mg Arya Commonly used to treat high blood pressureSAHPRA South AfricaRefundacja nie zagwarantuje dostępu do leku? Eksperci wskazują na ryzyko ograniczenia dostępu pacjentów do leczenia, naruszenia Konstytucji RP i niezgodności ze standardami prawa UE.INFARMA PolandEksperci: inwestycje w szczepienia mogą wspierać stabilność finansów publicznych. UE tworzy ku temu nowe możliwościINFARMA PolandLek z decyzją refundacyjną, którego pacjent nie dostanie. INFARMA apeluje do rządu o wykreślenie przepisów dopisanych po konsultacjach.INFARMA PolandPolityka lekowa powinna optymalizować efekt zdrowotny, nie tylko budżetINFARMA PolandDobre prawo wymaga dialogu, nie etykietINFARMA PolandClinical trials for medicines: Inclusion and Diversity Plan pilot findings publishedMHRA UKDecision: Orphan registered medicinal productsMHRA UKGuidance: Herbal medicines granted a traditional herbal registration (THR)MHRA UKMHRA launches patient safety essay competition for MedSafetyWeekMHRA UKTriheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disordersMHRA UKMHRA Safety Roundup: October 2026MHRA UKMHRA approves gene-editing treatment for children aged five and over with serious inherited blood disordersMHRA UKClass 2 Medicines Recall: Accord-UK Ltd, Lercanidipine Hydrochloride 10mg Film-Coated Tablets, EL(26)A/45MHRA UKClass 2 Medicines Recall: Advanz Pharma Limited, Mynzepli 40 mg/mL solution for injection in pre-filled syringe, EL(26)A/44MHRA UKField Safety Notices: 19 to 23 October 2026MHRA UKAccess, new active substance and biosimilar work sharing initiativesMHRA UKDecision: Medical devices given exceptional use authorisationsMHRA UKTransparency data: MHRA Performance DataMHRA UKNew MHRA research puts needle-free Strep A vaccine within reachMHRA UK#MedSafetyWeek (2 to 8 November 2026): Don't ignore suspected side effects, report them! Updates to the Yellow Card website and appMHRA UKClass 2 Medicines Recall: Xeal Pharma, Clopidogrel Oral Liquids (all strengths), EL(26)A/43MHRA UKMHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adultsMHRA UKMHRA approves new oral treatment for moderate to severe plaque psoriasisMHRA UKGuidance: COVID-19 test validation approved productsMHRA UKOpportunities for patients and the public to be involved in the work of the MHRAMHRA UKGovernment confirms indefinite recognition of CE marked medical devicesMHRA UKMedical devices regulations: targeted consultation on the indefinite recognition of CE marked devicesMHRA UKDecision: Parallel import licences granted in 2026MHRA UKDecision: Marketing authorisations granted in 2026MHRA UKIXCHIQ Chikungunya vaccine: UK marketing authorisation withdrawn following safety reviewMHRA UKMHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndromeMHRA UKUK regulator brings new AI and MedTech agenda to AdvaMedMHRA UKField Safety Notices: 5 to 9 October 2026MHRA UKField Safety Notices: 12 to 16 October 2026MHRA UKConsultation on schools holding Adrenaline Nasal Sprays for anaphylaxisMHRA UKMHRA consults on proposals to allow schools to keep spare adrenaline nasal sprays on siteMHRA UKNova Biomedical StatStrip ketone test strips: risk of disruption to blood ketone testing due to quality-control failures and supply interruption DSI/2026/013MHRA UK